Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Fulminant AQP4-IgG NMOSD Following Dostarlimab, Treated with Ravulizumab

Author:Amy Quek  Wei Ping Kay Ng  

Topic:Autoimmune Neurology  

Program Number:P2.083  

Author Institution:National University Hospital, Singapore, Singapore